4 ms·
This is one that I thought was compelling.[1] The trial ultimately failed but if you read the results the post-hoc analysis, it showed promise in mild and moder
by s1artibartfast 5y ago
This is one that I thought was compelling.[1] The trial ultimately failed but if you read the results the post-hoc analysis, it showed promise in mild and moderate subgroups of the ITT population. Most drugs today don't even target mild AD, but go after pre-symptomatic patients.
There was also benefit across most measures, but just not of statistical significance.
The trial had some major problems with appropriate controls, and is widely cited as a poster child for why the FDA should not require a control group to undergo invasive brain-surgery, and how this can taint the results.
It also showed a 89% reduction in amyloid Beta, the same proxy measure Biogen's aducanumab was recently approved based on.
https://n.neurology.org/content/neurology/71/3/202.full.pdf https://n.neurology.org/content/neurology/71/3/202.full.pdf
- mleonhard 5y agoThanks for checking. Alzheimer Management By Albumin Replacement (AMBAR) treatment has shown efficacy in slowing the progression of moderate & advanced stages disease [0, 1]. [0] https://doi.org/10.1080/14737175.2021.1960823 https://doi.org/10.1080/14737175.2021.1960823 [1] https://doi.org/10.1002/alz.12137 https://doi.org/10.1002/alz.12137
- s1artibartfast 5y agoYeah, is totally absurd that given the health care and social cost of of Alzheimer's we're not taking Broad shotgun approach to investigating potential remedies. There are a lot of treatments that's worth dumping several million dollars in even if they are low probability of having durable effects.
- mleonhard 5y agoIt doesn't happen because of the structure of society. Capitalism efficiently allocates capital, but does not maximize citizen quality-of-life.
- s1artibartfast 5y agoEither that or bureaucratic NIH grant grant approvers have no balls.
- mleonhard 5y agoDo you have any evidence to accuse NIH of fault, or is your comment pure speculation?
- s1artibartfast 5y agoI have been turned down for a half dozen grants in AD research I think could impact millions of lives, and see them funding bs and no impact projects. I obviously have biases and an axe to grind, but these are my opinions.
- mleonhard 5y agoThanks for explaining. How about publishing those rejected grant proposals?